ProductNum | picture | CAS No. | Name and description | Formula | Quick order |
---|---|---|---|---|---|
CLA1681 |
|
906068-56-2 |
Theralizumab | TGN1412 | TAB-08 | TABO8 95+% |
— | |
CLA1634 |
|
2226212-40-2 |
Anti-Human CD3xGPRC5D Bispecific Antibody ( Talquetamab; JNJ-64407564; JNJ-7564) 95+% |
— | |
CLA1610 |
|
2413817-97-5 |
Anti-Human CD3xClaudin18.2 Bispecific Antibody ( Gresonitamab; AMG 910; ) 95+% |
— | |
CLA1601 |
|
1801338-64-6 |
Anti-Human CD3ExCD20 Bispecific Antibody(Odronextamab) 95+% |
— | |
CLA1589 |
|
2134641-34-0 |
Anti-Human CD3ExCD20 (Epcoritamab; GEN3013) 95+% |
— | |
CLA1553 |
|
2119595-80-9 |
Anti-Human CD3xBCMA Bispecific Antibody(Teclistamab ) 95+% |
— | |
CLA1510 |
|
2101242-53-7 |
Anti-Human CD3xCEACAM5 Bispecific Antibody(Cibisatamab) 95+% |
— | |
CLA1489 |
|
1905409-39-3 |
Anti-Human CD3xCD20 Bispecific Antibody (Mosunetuzumab; BTCT-4465A; R07030816;CD20-TDB; RG7828; CD20 CD3 bispecific antibody.) 95+% |
— | |
CLA1360 |
|
1442657-12-6 |
Pasotuxizumab 95+% |
— | |
CLA1356 |
|
1630074-14-4 |
Denintuzumab (Anti-CD19) 95+% |
— | |
CLA1354 |
|
946415-62-9 |
Ontuxizumab (Anti-TEM1 / Endosialin / CD248) 95+% |
— | |
CLA1353 |
|
1269764-99-9 |
Coltuximab (Anti-CD19) 95+% |
— | |
CLA1345 |
|
1416147-64-2 |
Dapirolizumab pegol 95+% |
— | |
CLA1324 |
|
1313706-14-7 |
Pinatuzumab (Anti-Siglec-2 / CD22) 95+% |
— | |
CLA1308 |
|
1169956-08-4 |
Ocaratuzumab (Anti-CD20) 95+% |
— | |
CLA1293 |
|
1005198-65-1 |
Solitomab 95+% |
— | |
CLA1287 |
|
1238217-55-4 |
Vatelizumab (Anti-Integrin a2b1 (ITGA2 & ITGB1)) 95+% |
— | |
CLA1282 |
|
1188275-92-4 |
Narnatumab (Anti-MSPR / RON / CD136) 95+% |
— | |
CLA1275 |
|
934823-49-1 |
Urelumab (Anti-TNFRSF9 / 4-1BB / CD137) 95+% |
— | |
CLA1274 |
|
1174014-05-1 |
Ublituximab (Anti-CD20) 95+% |
— | |